AstraZeneca says Fasenra has been approved in the US
US regulatory approval for FasenraPositive results from late-stage trialsShares recover some lost groundAfter a string of disappointing clinical trial results which have weighed on AstraZeneca's (AZN) shares in the last month, the...
19 September 2024